ASCO Issues Recommendations on How to Fix the 340B Drug Pricing Program
In April, the American Society of Clinical Oncology (ASCO) released a policy statement recommending how to fix the 340B Drug Pricing Program. [ Read More ]
Subscribe
Sign Up Now!
To sign up for our newsletter or print publications, please enter your contact information below.